Danh Truong, PhD
Department of Sarcoma Medical Oncology, Division of Cancer Medicine
About Danh Truong
I am a researcher at MD Anderson Cancer Center specializing in bone and soft tissue sarcomas—a diverse group of malignancies comprising over 100 distinct subtypes. My primary focus is on desmoplastic small round cell tumors (DSRCT), Ewing sarcoma, and liposarcoma. These rare and aggressive cancers present unique biological challenges, which I address through a comprehensive, multi-modal omics approach. My research integrates single-cell and single-nucleus RNA sequencing, ATAC-sequencing, and spatial transcriptomics and proteomics to deeply characterize tumor biology and the surrounding microenvironment.
The first objective of my work is to unravel the molecular and cellular mechanisms driving sarcomagenesis. By dissecting the tumor microenvironment and identifying key transcriptional and epigenetic signatures, we aim to uncover novel drivers of tumor progression and therapeutic resistance. These insights are critical for informing the development of targeted, less toxic treatment strategies.
In parallel, my research explores an alternative paradigm to conventional cytotoxic therapies: repairing rather than destroying cancer cells. To this end, I am developing a mesenchymal stem cell (MSC) differentiation model to identify transcriptional regulators that guide lineage commitment into osteoblasts, myoblasts, and adipocytes. My central hypothesis is that many sarcomas arise from disrupted differentiation pathways, and by understanding these regulatory networks, we can identify and potentially correct the underlying errors that give rise to malignancy.
My long-term goal is to become a leader in sarcoma research, establishing a translational research program at an academic medical center. Given the rarity and complexity of sarcomas, there is a pressing need for collaborative, cross-disciplinary efforts to bridge basic science and clinical application. With a background that combines cancer biology and bioengineering, I am uniquely positioned to design and implement innovative tumor modeling platforms that not only validate biological hypotheses but also generate new insights into sarcoma pathogenesis and treatment.
Present Title & Affiliation
Primary Appointment
Assistant Professor, Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2018 | Arizona State University, US, Biomedical Engineering, PhD |
| 2014 | University of Texas at Arlington/University of Texas at Southwestern, US, Biomedical Engineering, MS |
| 2014 | University of Texas at Arlington, US, Biology, BS |
Postgraduate Training
| 2019-2023 | Postgraduate Fellow, Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
Experience & Service
Intramural Institutional Committee Activities
Member, Leiomyosarcoma Working Group, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Liposarcoma Working Group, The University of Texas MD Anderson Cancer Center, 2019 - Present
Extramural Institutional Committee Activities
Contributor, Open Single-cell Pediatric Cancer (OpenScPCA) Atlas project, MD Anderson Cancer Center, 2024 - Present
Member, CURE-OS, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Ultra rare sarcoma working group, The University of Texas MD Anderson Cancer Center, 2023 - Present
Co-leader, SASS-y, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, SARC Discovery Translational Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Honors & Awards
| 2024 | Young Investigator Travel Award for Strategic Advances in Sarcoma Science, SASS |
| 2023 | Young Investigator Travel Award for Strategic Advances in Sarcoma Science, SASS |
| 2023 | Trainee Grant Incentive Prize, MD Anderson Cancer Center |
| 2023 | SARC Career Development Award, SARC |
| 2023 | Daniel Benedict Gazan Fellowship in Sarcoma Research, MD Anderson Cancer Center |
| 2023 | SFA Research Grant, SFA |
| 2023 | AACR Scholar-in-Training, AACR |
| 2023 | AACR Early Career Hill Day, AACR |
| 2021 | Daniel Benedict Gazan Award in Sarcoma Research, MD Anderson Cancer Center |
| 2018 | ASU Convocation Speaker, ASU |
| 2018 | Graduate College Completion Fellowship, ASU |
| 2018 | Graduate & Professional Student Association Research Grant, ASU |
| 2018 | Graduate College Fellowship, ASU |
| 2017 | Outstanding SBHSE Graduate Research Assistant, ASU |
| 2017 - 2018 | Phoenix Chapter of ARCS Foundation Burton Scholar, ARCS |
| 2016 - 2017 | International Foundation for Ethical Research Graduate Fellowship, IFER |
| 2016 | Graduate & Professional Student Association Jumpstart Research Grant, ASU |
| 2016 | Molecular, Cellular, & Tissue Bioengineering Symposium Poster Presentation Award, ASU |
| 2016 | Graduate & Professional Student Association Travel Award, ASU |
| 2015 | School of BIological and Health Systems Engineering Block Funding Award, ASU |
| 2014 | Dean's Fellowship, ASU |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. A Spatial Proteomic Atlas of Desmoplastic Small Round Cell Tumors Reveals Inter- and Intra-tumoral Heterogeneity. Invited. GCC Single-Cell. Houston, Texas, US.
National Presentations
- 2026. Spatial Transcriptomic Profiling of Desmoplastic Small Round Cell Tumor Reveals a Phenotypic Spectrum of AR and Neural-like Tumor States. Gordon Research Conference. Houston, Texas, US.
- 2025. Characterizing Spatial Heterogeneity in Desmoplastic Small Round Cell Tumor. Poster. SASS. Houston, Texas, US.
- 2025. Adenosine pathway reshapes the liposarcoma TME and TIL metabolism. Poster. SASS. Houston, Texas, US.
- 2025. A Spatial Proteomic Atlas of Desmoplastic Small Round Cell Tumors Reveals Inter- and Intra-tumoral Heterogeneity. Poster. Nature Conference. Houston, Texas, US.
- 2025. Resolving Spatial Proteomic Heterogeneity and Cellular Neighborhoods in Desmoplastic Small Round Cell Tumors. Poster. Nature Conference. Houston, Texas, US.
- 2025. Leiomyosarcoma is characterized by two distinct subtypes driven by NFI or AP1 transcription factors. Poster. Chicago, Illinois, US.
- 2025. Co-targeting AR, mTOR, and PI3K inhibitors in DSRCT as a novel therapeutic approach. Poster. Chicago, Illinois, US.
- 2025. Spatial heterogeneity of tumor and stromal cells in desmoplastic small round cell tumors. Poster. Chicago, Illinois, US.
- 2025. Integrated multi-omics analyses discovers lineage plasticity in desmoplastic small round cell tumors. Poster. Chicago, Illinois, US.
- 2025. Leveraging FFPE single-nucleus RNA-sequencing for Osteosarcoma. Poster. Chicago, Illinois, US.
- 2024. Spatial Analysis of Desmoplastic Small Round Cell Tumors Integrated with Single-Cell Multi-omics. Poster. Strategic Advances in Sarcoma Science 2024 Annual Meeting. Bethesda, Maryland, US.
- 2024. Liposarcoma expanded tumor-infiltrating lymphocyte metabolism linked to LAG3 expression. Poster. Houston, Texas, US.
- 2024. Androgen receptor targeting in DSRCT. Invited. SARC Semiannual Meeting Pre-ASCO. Chicago, Illinois, US.
- 2024. LX-101, a novel, clinical stage, payload-bearing targeted therapy directed to the insulin-like growth factor receptor (IGF-1R), demonstrates potent anti-tumor activity in Ewing sarcoma animal models and desmoplastic small round cell tumor. Poster. Chicago, Illinois, US.
- 2024. Single-cell spatial proteomic analysis to explore the spatial heterogeneity of desmoplastic small round cell tumors. Poster. American Association for Cancer Research 2024 Annual Meeting. San Diego, CA, US.
- 2024. Characterization of neogenes in desmoplastic small round cell tumors. Poster. American Association for Cancer Research 2024 Annual Meeting. San Diego, CA, US.
- 2024. Multi-omic analysis of desmoplastic small sound cell tumors reveal distinct epithelial and neuroendocrine lineages. Poster. American Association for Cancer Research 2024 Annual Meeting. San Diego, CA, US.
- 2024. Understanding the molecular drivers that regulate Ewing sarcoma cell fate. Poster. American Association for Cancer Research 2024 Annual Meeting. San Diego, CA, US.
International Presentations
- 2024. Exploring the Heterogeneity of Desmoplastic Small Round Cell Tumors Through Multi-Omics Analyses Uncovers Epithelial and Neuroendocrine Lineages. Invited. CTOS 2024 Meeting. San Diego, US.
- 2024. Integrated atlas of single cell transcriptome and chromatin accessibility in leiomyosarcoma. Invited. CTOS 2024 Meeting. Houston, US.
- 2024. Single cell atlas of well-differentiated/dedifferentiated liposarcoma suggests underlying epigenetic programs driving transition between well- and dedifferentiated states. Invited. CTOS Meeting 2024. Houston, US.
- 2024. Revealing the tumor heterogeneity of desmoplastic small round cell tumors through spatial analysis. Invited. The Spatial Biology Week. Tolochenaz, CH.
- 2024. Targeting Differentiation Errors in Mesenchymal-Origin of Sarcomas. Invited. A.C. Carmargo Next Frontiers. Sao Paulo, BR.
- 2024. Identifying therapeutic vulnerabilities in desmoplastic small round cell tumor through multi-omics analyses. Poster. Advances in Pediatric Cancer Research. Toronto, CA.
- 2024. Detection of Intratumoral Heterogeneity of Sarcoma by ATAC-Seq. Invited. CTOS Spring webinar, US.
- 2024. Diversity of Liposarcoma expanded tumor-infiltrating lymphocytes metabolism linked to LAG3 expression. Poster. ESMO Sarcoma and Rare Cancers congress 2024. Houston, US.
- 2023. Multi-omic Analysis of Desmoplastic Small Round Cell Tumors Reveal Distinct Lineages. Poster. CTOS 2023 Annual Meeting. Dublin, IE.
- 2023. Understanding The Molecular Drivers That Regulate Ewing Sarcoma Cell Fate. Poster. CTOS 2023 Annual Meeting. Dublin, IE.
Grant & Contract Support
| Date: | 2026 - 2029 |
| Title: | Desmoplastic Small Round Cell Tumors (DSRCTs): Investigating Plasticity and Resistance Mechanisms to Improve Therapeutic Outcomes |
| Funding Source: | DoD |
| Role: | PI |
| ID: | HT9425-26-1-E047 |
| Date: | 2026 - 2030 |
| Title: | Preclinical & Clinical Digital Twins of ES & DSRCT: A joint initiative between academia, pharma, and patient advocates to model investigational agents |
| Funding Source: | DoD Rare Cancer Research Program |
| Role: | Co-I |
| Date: | 2025 - 2026 |
| Title: | Investigating lineage plasticity and EMT through the ZEB1-GRHL2 axis in DSRCT |
| Funding Source: | SFA |
| Role: | PI |
| Date: | 2024 - 2026 |
| Title: | Investigating the Spatial Heterogeneity and Cellular Taxonomy of DSRCTs |
| Funding Source: | The Rally Foundation |
| Role: | PI |
| ID: | FP00021534 |
| Date: | 2024 - 2025 |
| Title: | Identifying EWS::WT1 Control and The Utility of Neogenes in Desmoplastic Small Round Cell Tumors |
| Funding Source: | SFA |
| Role: | PI |
| ID: | FP00021880 |
| Date: | 2024 - 2028 |
| Title: | The epigenetic impact and therapeutic opportunity of AR directed therapy for DSRCT |
| Funding Source: | CPRIT |
| Role: | Co-I |
| ID: | RP240272 |
| Date: | 2023 - 2025 |
| Title: | Determining the therapeutic efficacy of targeting the Androgen Receptor in Desmoplastic Small Round Cell Tumors |
| Funding Source: | SARC |
| Role: | PI |
| ID: | FP00018991 |
| Date: | 2023 - 2025 |
| Title: | Neuroendocrine Reprogramming in DSRCT Resistance Mechanisms and Treatment Strategies |
| Funding Source: | DOD |
| Role: | Key |
| ID: | RA220160 |
Selected Publications
Peer-Reviewed Articles
- Beird, H, Ho, C, Cardenas Zuniga, R, Ahmed, A, Agyemang, C, Truong, D, Murgas, KA, Stephan, C, Park, YS, Powell, RT, Tym, JE, Landers, S, Schmidt, S, Osman, NM, Araujo, DM, Conley, AP, Somaiah, N, Al-Lazikani, B, Ludwig, JA, Futreal, A. Drug Screening of Sarcoma Cells. Cancer Research Communications 6(6):1425-1434, 2026. e-Pub 2026. PMID: 42165630.
- Denu RA, Zheng Z, Jiang Y, Satpati S, Kochat V, Anand K, Truong DD, Lynch AR, Padron W, Ingram DR, Wani KM, Shamsutdinova D, Bhalla AD, Landers SM, Ratan R, Somaiah N, Roland CL, Torres KE, Van Loo P, Soliman PT, Meyer LA, Lazar AJ, Keung EZ, Haddad EFN, Rai K. Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States. bioRxiv, 2026. e-Pub 2026. PMID: 42244620.
- Denu RA, Kochat V, Zheng Z, Satpati S, Truong DD, Arslan E, Weistuch C, Divenko M, Wu M, Padron W, Ingram DR, Wani KM, Wang WL, Landers SM, Beird HC, McCuisto JL, Simmons A, Albertorio-Saez LM, Maryanski DN, Szany CC, Venters BJ, Windham CL, Keogh MC, Torres KE, Roland CL, Keung EZ, Haddad EFN, Lazar AJ, Ludwig JA, Somaiah N, Rai K. Spatially-resolved single cell atlas of liposarcoma reveals lineage hierarchies, immune niches, and regulatory circuits. bioRxiv, 2026. e-Pub 2026. PMID: 41929055.
- Truong DD, Magrath JW, Murgas K, Fan J, Shamsutdinova D, Ingram D, Lazar A, Lee SB, Ludwig J. EWS::WT1 Isoform-Dependent Regulation of Neogenes in Desmoplastic Small Round Cell Tumors. bioRxiv, 2025. e-Pub 2025. PMID: 41040185.
- Truong DD, Weistuch C, Murgas KA, Admane P, King BL, Chauviere Lee J, Lamhamedi-Cherradi SE, Swaminathan J, Daw NC, Gordon N, Gopalakrishnan V, Gorlick RG, Somaiah N, Deasy JO, Mikos AG, Tannenbaum A, Ludwig J. Mapping the Single-cell Differentiation Landscape of Osteosarcoma. Clin Cancer Res, 2024. e-Pub 2024. PMID: 38775859.
- Magrath JW, Goldberg IN, Truong DD, Hartono AB, Sampath SS, Jackson CE, Ghosh A, Cardin DL, Zhang H, Ludwig JA, Lee SB. Enzalutamide induces cytotoxicity in desmoplastic small round cell tumor independent of the androgen receptor. Commun Biol 7(1):411, 2024. e-Pub 2024. PMID: 38575753.
- Truong, D, Lamhamedi-Cherradi, SE, Porter, RW, Krishnan, S, Swaminathan, J, Gibson, A, Lazar, A, Livingston, JA, Gopalakrishnan, V, Gordon, N, Daw, NC, Navin, N, Gorlick, R, Ludwig, JA. Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing. BMC cancer 23(1):488, 2023. e-Pub 2023. PMID: 37254069.
- Wu, C, Beird, H, Lamhamedi-Cherradi, SE, Soeung, M, Ingram, D, Truong, D, Porter, RW, Krishnan, S, Little, L, Gumbs, C, Zhang, J, Titus, M, Genovese, G, Ludwig, JA, Lazar, A, Hayes-Jordan, A, Futreal, A. Multi-site desmoplastic small round cell tumors are genetically related and immune-cold. npj Precision Oncology 6(1):21, 2022. e-Pub 2022. PMID: 35379887.
- Lamhamedi-Cherradi, SE, Maitituoheti, M, Menegaz, BA, Krishnan, S, Vetter, AM, Camacho, P, Wu, C, Beird, H, Porter, RW, Ingram, D, Ramamoorthy, V, Mohiuddin, S, McCall, DC, Truong, D, Cuglievan, B, Futreal, A, Velasco, AR, Anvar, NE, Utama, B, Titus, M, Lazar, A, Wang, W, Rodriguez-Aguayo, C, Ratan, R, Livingston, JA, Rai, K, MacLeod, R, Daw, NC, Hayes-Jordan, A, Ludwig, JA. The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma. Nature communications 13(1):3057, 2022. e-Pub 2022. PMID: 35650195.
- Truong, D, Lamhamedi-Cherradi, SE, Ludwig, JA. Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer. Journal of bone oncology 33:100419, 2022. e-Pub 2022. PMID: 35251924.
- Molina, ER, Chim, LK, Lamhamedi-Cherradi, SE, Mohiuddin, S, McCall, DC, Cuglievan, B, Krishnan, S, Porter, RW, Ingram, D, Wang, W, Lazar, A, Scott, DW, Truong, D, Daw, NC, Ludwig, JA, Mikos, AG. Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients. Oncotarget 13:521-533, 2022. e-Pub 2022. PMID: 35284040.
- Lamhamedi-Cherradi, SE, Mohiuddin, S, Mishra, DK, Krishnan, S, Velasco, AR, Vetter, AM, Pence, K, McCall, DC, Truong, D, Cuglievan, B, Menegaz, BA, Utama, B, Daw, NC, Molina, ER, Zielinski, RJ, Livingston, JA, Gorlick, R, Mikos, AG, Kim, M, Ludwig, JA. Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma. Cancer gene therapy 28(12):1325-1338, 2021. e-Pub 2021. PMID: 33408328.
- Saini, H, Rahmani Eliato, K, Veldhuizen, J, Zare, A, Allam, M, Silva, C, Kratz, A, Truong, D, Mouneimne, G, Labaer, J, Ros, R, Nikkhah, M. The role of tumor-stroma interactions on desmoplasia and tumorigenicity within a microengineered 3D platform. Biomaterials 247, 2020. e-Pub 2020. PMID: 32278213.
- Truong, D, Kratz, A, Park, J, Barrientos, ES, Saini, H, Nguyen, T, Pockaj, B, Mouneimne, G, Labaer, J, Nikkhah, M. A human organotypic microfluidic tumor model permits investigation of the interplay between patient-derived fibroblasts and breast cancer cells. Cancer Research 79(12):3139-3151, 2019. e-Pub 2019. PMID: 30992322.
- Truong, D, Fiorelli, R, Barrientos, ES, Melendez, EL, Sanai, N, Mehta, S, Nikkhah, M. A three-dimensional (3D) organotypic microfluidic model for glioma stem cells – Vascular interactions. Biomaterials 198:63-77, 2019. e-Pub 2019. PMID: 30098794.
- Nagaraju, S, Truong, D, Mouneimne, G, Nikkhah, M. Microfluidic Tumor–Vascular Model to Study Breast Cancer Cell Invasion and Intravasation. Advanced Healthcare Materials 7(9), 2018. e-Pub 2018. PMID: 29334196.
- Xu, C, Kuriakose, AE, Truong, D, Punnakitikashem, P, Nguyen, KT, Hong, Y. Enhancing anti-thrombogenicity of biodegradable polyurethanes through drug molecule incorporation. Journal of Materials Chemistry B 6(44):7288-7297, 2018. e-Pub 2018. PMID: 30906556.
- Peela, N, Barrientos, ES, Truong, D, Mouneimne, G, Nikkhah, M. Effect of suberoylanilide hydroxamic acid (SAHA) on breast cancer cells within a tumor-stroma microfluidic model. Integrative Biology (United Kingdom) 9(12):988-999, 2017. e-Pub 2017. PMID: 29188843.
- Migrino, RQ, Davies, HA, Truran, S, Karamanova, N, Franco, DA, Beach, TG, Serrano, GE, Truong, D, Nikkhah, M, Madine, J. Amyloidogenic medin induces endothelial dysfunction and vascular inflammation through the receptor for advanced glycation endproducts. Cardiovascular Research 113(11):1389-1402, 2017. e-Pub 2017. PMID: 28859297.
- Navaei, A, Moore, N, Sullivan, RT, Truong, D, Migrino, RQ, Nikkhah, M. Electrically conductive hydrogel-based micro-topographies for the development of organized cardiac tissues. RSC Advances 7(6):3302-3312, 2017. e-Pub 2017.
- Truong, D, Puleo, J, Llave, A, Mouneimne, G, Kamm, RD, Nikkhah, M. Breast cancer cell invasion into a three dimensional tumor-stroma microenvironment. Scientific reports 6, 2016. e-Pub 2016. PMID: 27678304.
- Peela, N, Sam, FS, Christenson, W, Truong, D, Watson, AW, Mouneimne, G, Ros, R, Nikkhah, M. A three dimensional micropatterned tumor model for breast cancer cell migration studies. Biomaterials 81:72-83, 2016. e-Pub 2016. PMID: 26724455.
- Navaei, A, Truong, D, Heffernan, J, Cutts, J, Brafman, D, Sirianni, RW, Vernon, B, Nikkhah, M. PNIPAAm-based biohybrid injectable hydrogel for cardiac tissue engineering. Acta Biomaterialia 32:10-23, 2016. e-Pub 2016. PMID: 26689467.
- Gao, G, Schilling, AF, Hubbell, K, Yonezawa, T, Truong, D, Hong, Y, Dai, G, Cui, X. Improved properties of bone and cartilage tissue from 3D inkjet-bioprinted human mesenchymal stem cells by simultaneous deposition and photocrosslinking in PEG-GelMA. Biotechnology Letters 37(11):2349-2355, 2015. e-Pub 2015. PMID: 26198849.
- Punnakitikashem, P, Truong, D, Menon, JU, Nguyen, KT, Hong, Y. Electrospun biodegradable elastic polyurethane scaffolds with dipyridamole release for small diameter vascular grafts. Acta Biomaterialia 10(11):4618-4628, 2014. e-Pub 2014. PMID: 25110284.
Review Articles
- Truong DD, Cardenas-Zuniga R, Ludwig JA. Desmoplastic Small Round Cell Tumors and the Role of Androgen Receptors. Curr Treat Options Oncol, 2025. e-Pub 2025. PMID: 40536706.
- Loft A, Emont MP, Weinstock A, Divoux A, Ghosh A, Wagner A, Hertzel AV, Maniyadath B, Deplancke B, Liu B, Scheele C, Lumeng C, Ding C, Ma C, Wolfrum C, Strieder-Barboza C, Li C, Truong DD, Bernlohr DA, Stener-Victorin E, Kershaw EE, Yeger-Lotem E, Shamsi F, Hui HX, Camara H, Zhong J, Kalucka J, Ludwig JA, Semon JA, Jalkanen J, Whytock KL, Dumont KD, Sparks LM, Muir LA, Fang L, Massier L, Saraiva LR, Beyer MD, Jeschke MG, Mori MA, Boroni M, Walsh MJ, Patti ME, Lynes MD, Bluher M, Ryden M, Hamda N, Solimini NL, Mejhert N, Gao P, Gupta RK, Murphy R, Pirouzpanah S, Corvera S, Tang S, Das SK, Schmidt SF, Zhang T, Nelson TM, O'Sullivan TE, Efthymiou V, Wang W, Tong Y, Tseng YH, Mandrup S, Rosen ED. Towards a consensus atlas of human and mouse adipose tissue at single-cell resolution. Nat Metab, 2025. e-Pub 2025. PMID: 40360756.
- Cuglievan, B, Kantarjian, HM, Rubnitz, JE, Cooper, T, Zwaan, CM, Pollard, J, DiNardo, C, Kadia, TM, Guest, E, Short, NJ, McCall, DC, Daver, N, Nunez, CA, Haddad, FG, Garcia, MB, Bhalla, K, Maiti, A, Catueno, S, Fiskus, WC, Carter, BZ, Gibson, A, Roth, M, Khazal, SJ, Tewari, P, Abbas, HA, Bourgeois, W, Andreeff, M, Shukla, N, Truong, D, Connors, JS, Ludwig, JA, Stutterheim, J, Salzer, E, Juul-Dam, KL, Sasaki, K, Mahadeo, KM, Tasian, SK, Borthakur, G, Dickson, S, Jain, N, Jabbour, EJ, Meshinchi, S, Garcia-Manero, G, Ravandi, F, Stein, EM, Kolb, EA, Issa, GC. Menin inhibitors in pediatric acute leukemia. Leukemia 38(10):2073-2084, 2024. e-Pub 2024. PMID: 39179671.
- Peela, N, Truong, D, Saini, H, Chu, H, Mashaghi, S, Ham, SL, Singh, S, Tavana, H, Mosadegh, B, Nikkhah, M. Advanced biomaterials and microengineering technologies to recapitulate the stepwise process of cancer metastasis. Biomaterials 133:176-207, 2017. e-Pub 2017. PMID: 28437628.
Other Articles
- Cherradi-Lamhamedi, SE, Truong, D, Ludwig, JA Understanding sarcoma drug resistance one cell at a time. Cancer Drug Resistance 5(1):90-92, 2022. PMID: 35582528.
Patents
- Mehdi NIkkhah, Roger Kamm, Danh D Truong. Engineering of a novel breast tumor microenvironment on a microfluidic chip, 2018. Patent Number: 10017724.
Patient Reviews
CV information above last modified September 01, 2026